PF-05190457

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NamePF-05190457
Drug Alias NamePF-5190457PF-05190457
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor antagonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsAlcohol DrinkingAlcoholismAlcohol-Related Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSingapore
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institute On Alcohol Abuse And AlcoholismPfizer Inc
Active IndicationsN/A
Inactive IndicationsAlcohol DrinkingAlcoholismAlcohol-Related Disorders +[4] 

Other Information

ATC CodeN/A
Related LinksN/A